Antiaging Quantum Living Inc. Cash Flow Statement
AAQL|5 years of annual SEC 10-K data (FY2021-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 5 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Operating Cash Flow
N/A
FY2025
Free Cash Flow
N/A
FY2025
Capital Expenditures
N/A
Cash used for long-term assets
Dividends Paid
N/A
FY2025
Key Data Points
- Altman Z-Score -0.87 (distress zone, below 1.23 threshold)
- Piotroski F-Score: 2/9 criteria passed
- Negative shareholders equity: Liabilities exceed assets
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net Income | - | -$720.4K | -$413.0K | -$43.4K | -$43.4K |
| Depreciation & Amortization | - | $144.3K | $7.0K | - | - |
| Operating Cash Flow | - | -$900.3K | -$649.4K | -$41.1K | -$41.1K |
| Capital Expenditures | - | - | - | $950 | $950 |
| Free Cash Flow | - | - | - | -$42.1K | -$42.1K |
| FCF Margin | - | - | - | -568.8% | -568.8% |